BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18364124)

  • 21. [Brief history and future prospects of treatment of childhood acute lymphocytic leukemia].
    Bessho F
    Rinsho Ketsueki; 1997 May; 38(5):380-4. PubMed ID: 9194379
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute lymphatic leukemia in Swedish children 1968-2001. The marked improvement of the survival can be ascribed to successful treatment].
    Kreuger A; Berglund G; Garwicz S; Mellander L; Söderhäll S; Ahström L; Gustafsson G
    Lakartidningen; 2004 Nov; 101(48):3890, 3893-4, 3897-8. PubMed ID: 15631223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time trends in the incidence of acute lymphoblastic leukemia among children 1976-2002: a population-based Nordic study.
    Svendsen AL; Feychting M; Klaeboe L; Langmark F; Schüz J
    J Pediatr; 2007 Nov; 151(5):548-50. PubMed ID: 17961705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Childhood acute leukemia: a single institution experience in La Plata, Argentina.
    Gómez SM; Schuttenberg V; Armendariz H; Alba L; Martinez M; Fynn A; Ferrère E; Delgado-Caffé A
    Med Pediatr Oncol; 2001 Mar; 36(3):383-5. PubMed ID: 11241441
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of childhood acute lymphoblastic leukemia.
    Stanulla M; Schrappe M
    Semin Hematol; 2009 Jan; 46(1):52-63. PubMed ID: 19100368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome.
    Luo XQ; Ke ZY; Huang LB; Guan XQ; Zhang YC; Zhang XL
    Pediatr Blood Cancer; 2009 Feb; 52(2):191-5. PubMed ID: 18989886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cord blood transplantation for acute lymphoblastic leukemia in children: analysis at a single institution].
    Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A; Yoshida M
    Rinsho Ketsueki; 2008 Dec; 49(12):1593-8. PubMed ID: 19110519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute lymphoblastic leukemia and hepatoblastoma in a family.
    Rafsanjani KA; Vossough P
    Pediatr Hematol Oncol; 2002; 19(7):521-3. PubMed ID: 12217198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
    Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Xu C; Dong L; Zhou M
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):290-4. PubMed ID: 18554450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of early treatment response in children with acute lymphoblastic leukemia: a single institution experience in Shanghai, China.
    Tie LJ; Gu LJ; Song DL; Jiang LM; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):5-9. PubMed ID: 19149913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission-similar outcomes after matched related and unrelated donor transplant: a study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon).
    Muñoz A; Diaz-Heredia C; Diaz MA; Badell I; Verdeguer A; Martinez A; Gomez P; Perez-Hurtado JM; Bureo E; Fernandez-Delgado R; Gonzalez-Valentin ME; Maldonado MS
    Pediatr Hematol Oncol; 2008 Jun; 25(4):245-59. PubMed ID: 18484470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
    Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
    Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia.
    Sawada A; Sakata N; Kishimoto T; Higuchi B; Koyama M; Kondo O; Sato E; Okamura T; Yasui M; Inoue M; Yoshioka A; Kawa K
    Leuk Res; 2009 Dec; 33(12):1710-3. PubMed ID: 19596431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. History of the treatment of childhood ALL: a paradigm for cancer cure.
    Simone JV
    Best Pract Res Clin Haematol; 2006; 19(2):353-9. PubMed ID: 16516133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anemia and survival in childhood acute lymphoblastic leukemia.
    Teuffel O; Stanulla M; Cario G; Ludwig WD; Rottgers S; Schafer BW; Zimmermann M; Schrappe M; Niggli FK
    Haematologica; 2008 Nov; 93(11):1652-7. PubMed ID: 18815194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and parent satisfaction of a physical therapy intervention program for children with acute lymphoblastic leukemia in the first 6 months of medical treatment.
    Gohar SF; Comito M; Price J; Marchese V
    Pediatr Blood Cancer; 2011 May; 56(5):799-804. PubMed ID: 21370414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.